Invesco Biotechnology & Genome ETF PBE
99.62 USD -1.22 (-1.21%)
At closeNov 10, 2026, 4:00 PM EST
99.62 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
99.06 Day range 100.33
75.50 52-week range 104.69
- YTD
- +21.27%
- 1 year
- +31.10%
- Market cap
- 307.43M
- EPS (ttm)
- 3.92
- P/E ratio
- 25.40
- YTD return
- +21.27%
- 1-year return
- +31.10%
- Volume
- 9.07K
- Avg volume
- 18.89K
- Open
- 100.16
- Previous close
- 100.84
- Day's range
- 99.06 – 100.33
- 52-week range
- 75.50 – 104.69
5D -4.72 (-4.55%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 69.17
- 200-day average
- 67.04
About Invesco Biotechnology & Genome ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
News
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention 
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules 
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications 
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead 
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits - US Judge Weighs Nationwide Ban On Abortion Pills
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' - 5 Top ETFs With Exposure To Biogen
3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
Your note
Sign in to keep a note on PBE — it syncs with the Stock Master app.